Positive and negative regulators of the vasopressin gene promoter in small cell lung cancer

Progress in Brain Research

Volumn 139, Issue , 2002, Pages 329-343

  Coulson, J M ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Activator; Enhancer; Neuron restrictive silencer factor; Repressor; SCLC; Transcription; Upstream stimulatory factor; Vasopressin

Indexed keywords

VASOPRESSIN;

CONFERENCE PAPER; GENE CONTROL; GENETIC TRANSCRIPTION; LUNG SMALL CELL CANCER; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

EID: 0036455810     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(02)39028-9     Document Type: Conference Paper

References (98)

1. Acampora, D., Postiglione, M.P., Avantaggiato, V., Di Bonito, M., Vaccarino, F.M., Michaud, J. and Simeone, A. (1999) Progressive impairment of developing neuroendocrine cell lineages in the hypothalamus of mice lacking the orthopedia gene. Genes Dev., 13: 2787-2800.
2. Ahmed, S.I., Coulson, J.M. and Woll, P.J. (2000) Detection of small cell lung cancer cells in the peripheral blood by RT-PCR for expressed neuropeptides. Proc. Am. Soc. Clin. Oncol., 19: 1901.
3. Anbazhagan, R., Tihan, T., Bornman, D.M., Johnston, J.C., Saltz, J.H., Weigering, A., Piantadosi, S. and Gabrielson, E. (1999) Classification of small cell lung cancer and pulmonary carcinoid by gene expression profiles. Cancer Res., 59: 5119-5122.
4. Andres, M.E., Burger, C., PeralRubio, M.J., Battaglioli, E., Anderson, M.E., Grimes, J., Dallman, J., Ballas, N. and Mandel, G. (1999) CoREST: A functional corepressor required for regulation of neural-specific gene expression. Proc. Natl. Acad. Sci. USA, 96: 9873-9878.
5. Ballas, N., Battaglioli, E., Atouf, F., Andres, M.E., Chenoweth, J., Anderson, M.E., Burger, C., Moniwa, M., Davie, J.R., Bowers, W.J., Federoff, H.J., Rose, D.W., Rosenfeld, M.G., Brehm, P. and Mandel, G. (2001) Regulation of neuronal traits by a novel transcriptional complex. Neuron, 31: 353-365.
6. Battaglioli, E., Andres, M.E. and Mandel, G. (2001) Unravelling the REST repressor complex. Mechanisms of Eukaryotic Transcriptional Regulation, Keystone Symposia Abstract Book p. 303.
7. Bessis, A., Champtiaux, N., Chatelin, L. and Changeux, J.P. (1997) The neuron-restrictive silencer element: A dual enhancer/silencer crucial for patterned expression of a nicotinic receptor gene in the brain. Proc. Natl. Acad. Sci. USA, 94: 5906-5911.
8. Brambilla, E., Lantuejoul, S. and Sturm, N. (2000) Divergent differentiation in neuroendocrine lung tumors. Semin. Diagn. Pathol., 17: 138-148.
9. Breen, G.A.M. and Jordan, E.M. (2000) Upstream stimulatory factor 2 stimulates transcription through an initiator element in the mouse cytochrome c oxidase subunit Vb promoter. Biochim. Biophys. Acta, 1517: 119-127.
10. Burbach, J.P., Luckman, S.M., Murphy, D. and Gainer, H. (2001) Gene regulation in the magnocellular hypothalamoneurohypophysial system. Physiol. Rev., 81: 1197-1267.
11. Burke, Z.D., Ho, M.Y., Morgan, H., Smith, M., Murphy, D. and Carter, D. (1997) Repression of vasopressin gene expression by glucocorticoids in transgenic mice: Evidence of a direct mechanism mediated by proximal 5′ flanking sequence. Neuroscience, 78: 1177-1185.
12. Carter, D.A. and Murphy, D. (1989) Independent regulation of neuropeptide mRNA level and poly(A) tail length. J. Biol. Chem., 264: 6601-6603.
13. Chen, H., Biel, M.A., Borges, M.W., Thiagalingam, A., Nelkin, B.D., Baylin, S.B. and Ball, D.W. (1997) Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: Transcriptional regulation by dual inhibitory regions. Cell Growth Differ., 8: 677-686.
14. Chen, Z.F., Paquette, A.J. and Anderson, D.J. (1998) NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis. Nat. Genet., 20: 136-142.
15. Chong, J.H.A., Tapiaramirez, J., Kim, S., Toledoaral, J.J., Zheng, Y.C., Boutros, M.C., Altshuller, Y.M., Frohman, M.A., Kraner, S.D. and Mandel, G. (1995) REST - A mammalian silencer protein that restricts sodium-channel gene-expression to neurons. Cell, 80: 949-957.
16. Coulson, J.M., Stanley, J., Staff, D. and Woll, J.P. (1997) Evaluation of vasopressin (AVP) and Vla receptor expression in SCLC cell lines: Potential for an autocrine growth loop?. Lung Cancer, 18: A599.
17. Coulson, J.M., Fiskerstrand, C.E., Woll, P.J. and Quinn, J.P. (1999a) Arginine vasopressin promoter regulation is mediated by a neuron-restrictive silencer element in small cell lung cancer. Cancer Res., 59: 5123-5127.
18. Coulson, J.M., Fiskerstrand, C.E., Woll, P.J. and Quinn, J.P. (1999b) E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer. Biochem. J., 344: 961-970.
19. Coulson, J.M., Stanley, J. and Woll, P.J. (1999c) Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer. Br. J. Cancer, 80: 1935-1944.
20. Coulson, J.M., Edgson, J.L., Quinn, J.P. and Woll, P.J. (2000a) Characterisation and exploitation of a novel neuron-restrictive silencer factor isoform in neuroendocrine small cell lung cancer. Lung Cancer, 29: 640.
21. Coulson, J.M., Edgson, J.L., Quinn, J.P. and Woll, P.J. (2000b) The role of upstream stimulatory factor in expression of the vasopressin gene in lung cancer. Lung Cancer, 29: 699.
22. Coulson, J.M., Edgson, J.L., Woll, P.J. and Quinn, J.P. (2000c) A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: A potential role in derepression of neuroendocrine genes and a useful clinical marker. Cancer Res., 60: 1840-1844.
23. Coulson, J.M., Ahmed, S.I., Quinn, J.P. and Woll, P.J. (2002a) Detection of small cell lung cancer by RT-PCR for neuropeptides, neuropeptide receptors, or a splice variant of the neuron restrictive silencer factor. In: B. Driscoll (Ed.), Methods in Molecular Medicine: Lung Cancer, Vol. 75; Lung Cancer, Vol. 2 Diagnostic and Therapeutic Methods and Reviews, Chapter 20, Humana Press, Totowa, Englewood Cliffs, NJ.
24. Coulson, J.M., Ocejo-Garcia, M. and Woll, P.J. (2002b) The neuroendocrine phenotype of small cell lung cancer. In: B. Driscoll (Ed.), Methods in Molecular Medicine, Vol. 74: Lung Cancer; Vol. 1 Molecular Pathology Methods and Reviews, Chapter 4. Humana Press, Totowa, Englewood Cliffs, NJ.
25. Dockray, G.J. (1999) Topical review. Gastrin and gastric epithelial physiology. J. Physiol., 518: 315-324.
26. Fay, M.J., Friedmann, A.S., Yu, X.M. and North, W.G. (1994) Vasopressin and vasopressin-receptor immunoreactivity in small-cell lung-carcinoma (SCCL) cell-lines - Disruption in the activation cascade of V-la-receptors in variant SCCL. Cancer Lett., 82: 167-174.
27. Friedmann, A.S., Memoli, V.A. and North, W.G. (1993) Vasopressin and oxytocin production by non-neuroendocrine lung carcinomas - An apparent low incidence of gene-expression. Cancer Lett., 75: 79-85.
28. Friedmann, A.S., Fay, M.J., Memoli, V.A. and North, W.G. (1995) Factors regulating the production of vasopressin-associated human neurophysin by small-cell carcinoma of the lung - Evaluation by computer-enhanced quantitative immunocytochemistry. Neuropeptides, 28: 183-189.
29. Gao, E.W., Wang, Y., Alcorn, J.L. and Mendelson, C.R. (1997) The basic helix-loop-helix-zipper transcription factor USF1 regulates expression of the surfactant protein-A gene. J. Biol. Chem., 272: 23398-23406.
30. Girard, L., Zochbauer-Muller, S., Virmani, A.K., Gazdar, A.F. and Minna, J.D. (2000) Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res., 60: 4894-4906.
31. Grace, C.O., Fink, G. and Quinn, J.P. (1999) Characterization of potential regulatory elements within the rat arginine vasopressin proximal promoter. Neuropeptides, 33: 81-90.
32. Graziano, S.L., Tatum, A., Herndon, J.E., Box, J., Memoli, V., Green, M.R. and Kern, J.A. (2001) Use of neuroendocrine markers, p53, and HER2 to predict response to chemotherapy in patients with stage III non-small cell lung cancer: A cancer and leukemia group B study. Lung Cancer, 33: 115-123.
33. Greenall, A., Willingham, N., Cheung, E., Boam, D.S. and Sharrocks, A.D. (2001) DNA binding by the ETS-domain transcription factor PEA3 is regulated by intramolecular and intermolecular protein. Protein interactions. J. Biol. Chem., 276: 16207-16215.
34. Grimes, J.A., Nielsen, S.J., Battaglioli, E., Miska, E.A., Speh, J.C., Berry, D.L., Atouf, F., Holdener, B.C., Mandel, G. and Kouzarides, T. (2000) The co-repressor mSin3a is a functional component of the REST-CoREST repressor complex. J. Biol. Chem., 275: 9461-9467.
35. Hakimi, M.A., Bochar, D.A., Chenoweth, J., Lane, W.S., Mandel, G. and Shiekhattar, R. (2002) A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes. Proc. Natl. Acad. Sci. USA, 99: 7420-7425.
36. Heasley, L.E. (2001) Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene, 20: 1563-1569.
37. Heckert, L.L. (2001) Activation of the rat follicle-stimulating hormone receptor promoter by steroidogenic factor 1 is blocked by protein kinase A and requires upstream stimulatory factor binding to a proximal E box element. Mol. Endocrinol., 15: 704-715.
38. Hellmann, G.M., Fields, W.R. and Doolittle, D.J. (2001) Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells. Toxicol. Sci., 61: 154-163.
39. Hosoya, T., Oda, Y., Takahashi, S., Morita, M., Kawauchi, S., Ema, M., Yamamoto, M. and Fujii-Kuriyama, Y. (2001) Defective development of secretory neurones in the hypothalamus of Amt2-knockout mice. Genes Cells, 6: 361-374.
40. Huang, Y.F., Myers, S.J. and Dingledine, R. (1999) Transcriptional repression by REST: Recruitment of Sin3a and histone deacetylase to neuronal genes. Nat. Neurosci., 2: 867-872.
41. Ito, T., Udaka, N., Ikeda, M., Yazawa, T., Kageyama, R. and Kitamura, H. (2001) Significance of proneural basic helix-loop-helix transcription factors in neuroendocrine differentiation of fetal lung epithelial cells and lung carcinoma cells. Histol. Histopathol., 16: 335-343.
42. Iwasaki, Y., Oiso, Y., Saito, H. and Majzoub, J.A. (1997) Positive and negative regulation of the rat vasopressin gene promoter. Endocrinology, 138: 5266-5274.
43. Jin, X.W., Shearman, L.P., Weaver, D.R., Zylka, M.J., DeVries, G.J. and Reppert, S.M. (1999) A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell, 96: 57-68.
44. Johnson, B.E., Chute, J.P., Rushin, J., Williams, J., Le, P.T., Venzon, D. and Richardson, G.E. (1997) A prospective study of patients with lung cancer and hyponatremia of malignancy, Am. J. Respir. Crit. Care Med., 156: 1669-1678.
45. Jones, F.S. and Meech, R. (1999) Knockout of REST NRSF shows that the protein is a potent repressor of neuronally expressed genes in non-neural tissues, Bioessays, 21: 372-376.
46. Kim, J.K., Summer, S.N., Wood, W.M. and Schrier, R.W. (1996) Osmotic and non-osmotic regulation of arginine vasopressin (AVP) release, mRNA, and promoter activity in small cell lung carcinoma (SCLC) cells. Mol. Cell. Endocrinol., 123: 179-186.
47. Lee, J.H., Shimojo, M., Chai, Y.G. and Hersh, L.B. (2000) Studies on the interaction of REST4 with the cholinergic repressor element-I/neuron restrictive silencer element. Mol. Brain Res., 80: 88-98.
48. Lonnerberg, P., Schoenherr, C.J., Anderson, D.J. and Ibanez, C.F. (1996) Cell type-specific regulation of choline acetyl-transferase gene expression - Role of the neuron-restrictive silencer element and cholinergic-specific enhancer sequences. J. Biol. Chem., 271: 33358-33365.
49. Luo, X. and Sawadogo, M. (1996) Functional domains of the transcription factor USF2: Atypical nuclear localization signals and context-dependent transcriptional activation domains. MoL Cell Biol., 16: 1367-1375.
50. MacKinnon, A.C., Waters, C., Rahman, I., Harani, N., Rintoul, R., Haslett, C. and Sethi, T. (2000) [Arg(6), D-Trp(7,9), N(me)Phe(8)]-substance P (6-11) (antagonist G) induces AP-1 transcription and sensitizes cells to chemotherapy. Br. J. Cancer, 83: 941-948.
51. McCabe, J.T. and Burrell, A.S. (2001) Alterations of AP-1 and CREB protein DNA binding in rat supraoptic and paraventricular nuclei by acute and repeated hyperosmotic stress. Brain Res. Bull., 55: 347-358.
52. Mendelson, S.C., Morrison, C.F., McAllister, J., Paterson, J.M., Dobson, S.P., Mulderry, P.K. and Quinn, J.P. (1995) Repression of preprotachykinin-A promoter activity is mediated by a proximal promoter element. Neuroscience, 65: 837-847.
53. Mohr, E., Prakash, N., Vieluf, K., Fuhrmann, C., Buck, F. and Richter, D. (2001) Vasopressin mRNA localization in nerve cells: Characterization of cis-acting elements and trans-acting factors. Proc. Natl. Acad. Sci. USA, 98: 7072-7079.
54. Murphy, D., Funkhouser, J., Ang, H.L., Foo, N.C. and Carter, D. (1993) Extrahypothalamic expression of the vasopressin and oxytocin genes. Ann. N.Y. Acad. Sci., 689: 91-106.
55. Naruse, Y., Aoki, T., Kojima, T. and Mori, N. (1999) Neural restrictive silencer factor recruits mSin3 and histone deacetylase complex to repress neuron-specific target genes, Proc. Natl. Acad. Sci. USA, 96: 13691-13696.
56. North, W.G. (2000) Gene regulation of vasopressin and vasopressin receptors in cancer. Exp. Physiol., 85: 27S-40S.
57. North, W.G. and Yu, X.M. (1993) Forms of neurohypophyseal peptides generated by tumors, and factors regulating their expression. Regul. Pept., 45: 209-216.
58. North, W.G., Pai, S., Friedmann, A., Yu, X.M., Fay, M. and Memoli, V. (1995) Vasopressin gene-related products are markers of human breast-cancer. Breast Cancer Res. Treat., 34: 229-235.
59. North, W.G., Fay, M.J., Longo, K.A. and Du, J.L. (1998) Expression of all known vasopressin receptor subtypes by small cell tumors implies a multifaceted role for this neuropeptide, Cancer Res., 58: 1866-1871.
60. North, W.G., Fay, M.J. and Du, J.L. (1999) MCF-7 breast cancer cells express normal forms of all vasopressin receptors plus an abnormal V2R. Peptides, 20: 837-842.
61. Ocejo-Garcia, M., Ahmed, S.I., Coulson, J.M, and Woll, P.J. (2001) Use of RT-PCR to detect co-expression of neuropeptides and their receptors in lung cancer. Lung Cancer, 33: 1-9.
62. Okazaki, T., Ishikawa, T., Nishimori, S., Igarashi, T., Hata, K, and Fujita, T. (1997) Hyperosmolarity-induced gene stimulation is mediated by the negative calcium responsive element. J. Biol. Chem., 272: 32274-32279.
63. Ouellette, D., Desbiens, G., Emond, C. and Beauchamp, G. (1998) Lung cancer in women compared with men: Stage, treatment, and survival. Ann. Thorac. Surg., 66: 1140-1143.
64. Palm, K., Belluardo, N., Metsis, M. and Timmusk, T. (1998) Neuronal expression of zinc finger transcription factor REST/NRSF/XRB gene. J. Neurosci., 18: 1280-1296.
65. Palm, K., Metsis, M. and Timmusk, T. (1999) Neuron-specific splicing of zinc finger transcription factor REST/NRSF/XBR is frequent in neuroblastomas and conserved in human, mouse and rat. Mol. Brain Res., 72: 30-39.
66. Paquette, A.J., Perez, S.E. and Anderson, D.J. (2000) Constitutive expression of the neuron-restrictive silencer factor (NRSF)/REST in differentiating neurons disrupts neuronal gene expression and causes axon pathfinding errors in vivo. Proc. Natl. Acad. Sci. USA, 97: 12318-12323.
67. Paterson, J.M., Mendelson, S.C., McAllister, J., Morrison, C.F., Dobson, S., Grace, C. and Quinn, J.P. (1995a) Three immediate-early gene response elements in the proximal preprotachykinin - A promoter in two functionally distinct domains. Neuroscience, 66: 921-932.
68. Paterson, J.M., Morrison, C.F., Mendelson, S.C., McAllister, J. and Quinn, J.P, (1995b) An upstream stimulatory factor (USF) binding motif is critical for rat preprotachykinin - A promoter activity in PC12 cells. Biochem. J., 310: 401-406.
69. Pearse, A.G. (1969) The cytochemistry and ultrastructure of polypeptide hormone producing cells of the APUD series, and the embryonic, physiologic and pathologic implications of the concept. J. Histochem. Cytochem., 17: 303-313.
70. Quinn, J.P., Bubb, V.J., Marshall-Jones, Z.V. and Coulson, J.M. (2002) Neuron restrictive silencer factor (NRSF) as a modulator of neuropeptide gene expresssion. Regulatory Peptides, in press.
71. Ribeiro, A., Pastier, D., Kardassis, D., Chambaz, J. and Cardot, P. (1999) Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein a-II gene. J. Biol. Chem., 274: 1216-1225.
72. Risse-Hackl, G., Adamkiewicz, J., Wimmel, A. and Schuermann, M. (1998) Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Oncogene, 16: 3057-3068.
73. Roopra, A., Sharling, L., Wood, I.C., Briggs, T., Bachfischer, U., Paquette, A.J. and Buckley, N.J. (2000) Transcriptional repression by neuron-restrictive silencer factor is mediated via the Sin3-histone deacetylase complex, Mol. Cell. Biol., 20: 2147-2157.
74. Roy, A.L., Meisterernst, M., Pognonec, P. and Roeder, R.G. (1991) Cooperative interaction of an initiator-binding transcription initiation-factor and the helix loop helix activator USF. Nature, 354: 245-248.
75. Sausville, E., Carney, D. and Battey, J. (1985) The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J. Biol. Chem., 260: 10236-10241.
76. Schoenherr, C.J. and Anderson, D.J. (1995) The neuron-restrictive silencer factor (NRSF) - A coordinate repressor of multiple neuron-specific genes. Science, 267: 1360-1363.
77. Schoenherr, C.J., Paquette, A.J. and Anderson, D.J. (1996) Identification of potential target genes for the neuron-restrictive silencer factor. Proc. Natl. Acad. Sci. USA, 93: 9881-9886.
78. Seethalakshmi, L., Mitra, S.P., Dobner, P.R., Menon, M. and Carraway, R.E. (1997) Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations. Prostate, 31: 183-192.
79. Seth, K.A. and Majzoub, J.A. (2001) Repressor element silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) can act as an enhancer as well as a repressor of corticotropin-releasing hormone gene transcription. J. Biol. Chem., 276: 13917-13923.
80. Sethi, T. and Rozengurt, E. (1991) Multiple neuropeptides stimulate clonal growth of small-cell lung-cancer - Effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin. Cancer Res., 51: 3621-3623.
81. Shimojo, M., Paquette, A.J., Anderson, D.J. and Hersh, L.B. (1999) Protein kinase A regulates cholinergic gene expression in PC 12 cells: REST4 silences the silencing activity of neuron-restrictive silencer factor/REST. Mol. Cell. Biol., 19: 6788-6795.
82. Shimojo, M., Lee, J.H. and Hersh, L.B. (2001) Role of zinc finger domains of the transcription factor neuron-restrictive silencer factor/repressor element-1 silencing transcription factor in DNA binding and nuclear localization. J. Biol. Chem., 276: 13121-13126.
83. Si-Hoe, S.L., Carter, D. and Murphy, D. (2001) Species- and tissue-specific physiological regulation of vasopressin mRNA poly(A) tail length. Physiol. Genomics, 5: 1-9.
84. Sirito, M., Lin, Q., Maity, T. and Sawadogo, M. (1994) Ubiquitous expression of the 43-kDa and 44-kDa forms of transcription factor USF in mammalian-cells. Nucleic Acids Res., 22: 427-433.
85. Sirito, M., Lin, Q., Deng, J.M., Behringer, R.R. and Sawadogo, M. (1998) Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice. Proc. Natl. Acad. Sci. USA, 95: 3758-3763.
86. Takahashi, K., Nishiyama, C., Okumura, K., Ra, C., Ohtake, Y. and Yokota, T. (2001) Molecular cloning of rat USF2 cDNA and characterization of splicing variants. Biosci. Biotechnol. Biochem., 65: 56-62.
87. Tang, D.L., Rundle, A., Warburton, D., Santella, R.M., Tsai, W.Y., Chiamprasert, S., Hsu, Y.Z. and Perera, F.P. (1998) Associations between both genetic and environmental biomarkers and lung cancer: Evidence of a greater risk of lung cancer in women smokers. Carcinogenesis, 19: 1949-1953.
88. Terasaki, T., Matsuno, Y., Shimosato, Y., Yamaguchi, K., Ichinose, H., Nagatsu, T. and Kato, K. (1994) Establishment of a human small-cell lung-cancer cell-line producing a large amount of antidiuretic hormone. Jpn. J. Cancer Res., 85: 718-722.
89. Thiel, G., Lietz, M. and Cramer, M. (1998) Biological activity and modular structure of RE-1-silencing transcription factor (REST), a repressor of neuronal genes. J. Biol. Chem., 273: 26891-26899.
90. Van Waardenburg, R.C., Meijer, C., Pinto-Sietsma, S.J., de Vries, E.G., Timens, W. and Mulder, N.M. (1998) Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines. Anticancer Res., 18: 91-95.
91. Verbeeck, M.A.E., Adan, R.A.H. and Burbach, J.P.H. (1990) Vasopressin gene-expression is stimulated by cyclic-AMP in homologous and heterologous expression systems. FEBS Lett., 272: 89-93.
92. Verbeeck, M.A.E., Sutanto, W. and Burbach, J.P.H. (1991) Regulation of vasopressin messenger-RNA levels in the small-cell lung-carcinoma cell-line GLC-8 - Interactions between glucocorticoids and second messengers. Mol. Endocrinol., 5: 795-801.
93. Viollet, B., LefrancoisMartinez, A.M., Henrion, A., Kahn, A., Raymondjean, M. and Martinez, A. (1996) Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms. J. Biol. Chem., 271: 1405-1415.
94. Woll, P. (1996) Growth-factors and cancer. In: H.I. Pass, J.B. Mitchell, D.H. Johnson and A.T. Turrisi (Eds.), Lung Cancer: Principles and Practice. Lippincott-Raven, Philadelphia, PA, pp. 123-131.
95. Woll, P.J. and Hart, I.R. (1995) Gene-therapy for lung-cancer. Ann. Oncol., 6: 73-77.
96. Woll, P.J. and Rozengurt, E. (1989) Multiple neuropeptides mobilise calcium in small cell lung cancer: Effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensin. Biochem. Biophys. Res. Commun., 164: 66-73.
97. Yoo, J., Jeong, M.J., Lee, S.S., Lee, K.I., Kwon, B.M., Kim, D.S., Park, Y.M. and Han, M.Y. (2001) The neuron restrictive silencer factor can act as an activator for dynamin I gene promoter activity in neuronal cells. Biochem. Biophys. Res. Commun., 283: 928-932.
98. Yoon, S.O. and Chikaraishi, D.M. (1992) Tissue-specific transcription of the rat tyrosine hydroxylase gene requires synergy between an AP-1 motif and an overlapping E box-containing dyad. Neuron, 9: 55-67.